Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: AMEX:XTNT
- CUSIP: N/A
- Web: N/A
- Market Cap: $7.8 million
- Outstanding Shares: 17,933,000
- 50 Day Moving Avg: $0.50
- 200 Day Moving Avg: $0.53
- 52 Week Range: $0.29 - $2.37
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.89
- P/E Growth: -0.020
- Annual Revenue: $91.11 million
- Price / Sales: 0.09
- Book Value: ($0.65) per share
- Price / Book: -0.67
- Average Volume: 869,364 shs.
- Short Ratio: 1.69
Frequently Asked Questions for Xtant Medical Holdings (AMEX:XTNT)
What is Xtant Medical Holdings' stock symbol?
Xtant Medical Holdings trades on the AMEX under the ticker symbol "XTNT."
How were Xtant Medical Holdings' earnings last quarter?
Xtant Medical Holdings Inc (AMEX:XTNT) issued its earnings results on Tuesday, May, 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.30) by $0.01. The business had revenue of $22.08 million for the quarter. View Xtant Medical Holdings' Earnings History.
Where is Xtant Medical Holdings' stock going? Where will Xtant Medical Holdings' stock price be in 2017?
3 brokers have issued 1-year target prices for Xtant Medical Holdings' stock. Their forecasts range from $1.50 to $3.50. On average, they expect Xtant Medical Holdings' stock price to reach $2.50 in the next year. View Analyst Ratings for Xtant Medical Holdings.
Who are some of Xtant Medical Holdings' key competitors?
Some companies that are related to Xtant Medical Holdings include Immune Pharmaceuticals (IMNP), GenVec (GNVC), Roka Bioscience (ROKA), Kitov Pharmaceuticals Holdings Ltd (KTOV), Repros Therapeutics (RPRX), Onconova Therapeutics (ONTX), Soligenix (SNGX), Lombard Medical (EVAR), Celsion (CLSN), Mateon Therapeutics (MATN), RXi Pharmaceuticals Corp (RXII), Interpace Diagnostics Group (IDXG), Cerulean Pharma (CERU), TearLab Corp (TEAR), OncoGenex Pharmaceuticals (OGXI), Jaguar Animal Health (JAGX), Windtree Therapeutics (WINT) and Avinger (AVGR).
Who owns Xtant Medical Holdings stock?
Xtant Medical Holdings' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Perkins Capital Management Inc. (3.79%) and KCG Holdings Inc. (0.00%). Company insiders that own Xtant Medical Holdings stock include Daniel S Goldberger, David Louis Kirschman and Kent L Swanson. View Institutional Ownership Trends for Xtant Medical Holdings.
Who sold Xtant Medical Holdings stock? Who is selling Xtant Medical Holdings stock?
Who bought Xtant Medical Holdings stock? Who is buying Xtant Medical Holdings stock?
Xtant Medical Holdings' stock was bought by a variety of institutional investors in the last quarter, including KCG Holdings Inc.. Company insiders that have bought Xtant Medical Holdings stock in the last two years include Daniel S Goldberger, David Louis Kirschman and Kent L Swanson. View Insider Buying and Selling for Xtant Medical Holdings.
How do I buy Xtant Medical Holdings stock?
Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Xtant Medical Holdings stock cost?
One share of Xtant Medical Holdings stock can currently be purchased for approximately $0.44.
Earnings History for Xtant Medical Holdings (AMEX:XTNT)Earnings History by Quarter for Xtant Medical Holdings (AMEX:XTNT)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/9/2017||Q1 2017||($0.30)||($0.29)||$22.08 million||View||Listen|
|3/9/2017||Q4 2016||($0.30)||($0.31)||$24.45 million||$24.47 million||View||Listen|
|5/4/2016||Q1||($0.39)||($0.44)||$21.94 million||$20.98 million||View||N/A|
|3/15/2016||Q415||($0.22)||$0.97||$23.34 million||$22.30 million||View||N/A|
|11/11/2015||Q3||($0.15)||($0.64)||$19.64 million||$17.69 million||View||Listen|
Earnings Estimates for Xtant Medical Holdings (AMEX:XTNT)
Current Year EPS Consensus Estimate: $-0.890 EPS
Next Year EPS Consensus Estimate: $-0.490 EPS
Dividend History for Xtant Medical Holdings (AMEX:XTNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Xtant Medical Holdings (AMEX:XTNT)Insider Trades by Quarter for Xtant Medical Holdings (AMEX:XTNT)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/9/2016||Daniel S Goldberger||CEO||Buy||5,000||$2.34||$11,700.00|| |
|12/3/2015||Kent L. Swanson||Director||Buy||3,300||$2.83||$9,339.00|| |
|11/20/2015||David Louis Kirschman||EVP||Buy||2,000||$2.99||$5,980.00|| |
|11/20/2015||Kent L. Swanson||Director||Buy||5,000||$3.00||$15,000.00|| |
|11/19/2015||David Louis Kirschman||EVP||Buy||2,000||$2.90||$5,800.00|| |
|11/16/2015||Daniel S Goldberger||CEO||Buy||3,000||$2.80||$8,400.00|| |
Headline Trends for Xtant Medical Holdings (AMEX:XTNT)
Latest Headlines for Xtant Medical Holdings (AMEX:XTNT)
|Xtant Medical Announces Rescheduling of Annual Meeting - GlobeNewswire (press release)|
globenewswire.com - May 27 at 6:56 AM
|Xtant Medical Holdings Inc (XTNT) Receives "Buy" Rating from Maxim Group|
www.americanbankingnews.com - May 22 at 10:54 AM
|Xtant Medical in-licenses Sites Medical's OsteoSync Ti|
seekingalpha.com - May 17 at 12:15 AM
|Xtant Medical Holdings (XTNT) Announces Licensing Agreement for Sites Medical's OsteoSync Ti Technology - StreetInsider.com|
www.streetinsider.com - May 16 at 8:03 AM
|Xtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology|
finance.yahoo.com - May 16 at 8:03 AM
|Xtant Medical Holdings' (XTNT) CEO Carl O'Connell on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha|
seekingalpha.com - May 15 at 8:17 AM
|Xtant Medical Holdings, Inc. 2017 Q1 - Results - Earnings Call Slides|
seekingalpha.com - May 14 at 12:06 PM
|Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners|
finance.yahoo.com - May 12 at 3:19 PM
|Edited Transcript of XTNT earnings conference call or presentation 10-May-17 2:00pm GMT|
finance.yahoo.com - May 12 at 3:19 PM
|Xtant Medical Holdings Inc (XTNT) Announces Earnings Results|
www.americanbankingnews.com - May 10 at 3:10 PM
|Xtant™ Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period|
finance.yahoo.com - May 9 at 8:21 PM
|Xtant Medical Announces Release of First Quarter 2017 Results on May 9, 2017|
finance.yahoo.com - May 1 at 7:50 PM
|Xtant Medical Holdings (XTNT) Getting Favorable News Coverage, Study Finds|
www.americanbankingnews.com - May 1 at 2:10 PM
|Xtant Medical Holdings Inc (XTNT) to Release Quarterly Earnings on Tuesday|
www.americanbankingnews.com - April 30 at 7:33 AM
|Xtant Medical Holdings (XTNT) Receiving Positive News Coverage, Report Shows|
www.americanbankingnews.com - April 26 at 8:13 AM
|BRIEF-Xtant, units entered forbearance agreement with Silicon Valley Bank|
www.reuters.com - April 25 at 8:25 AM
|Xtant Medical Recognized as Montana Ambassador Business of the Year|
finance.yahoo.com - April 25 at 8:25 AM
|Xtant Medical Holdings (XTNT) Receives Media Impact Score of -0.35|
www.americanbankingnews.com - April 21 at 7:47 AM
|XTANT MEDICAL HOLDINGS, INC. Files SEC form 10-K, Annual Report|
biz.yahoo.com - March 30 at 8:31 AM
|Q4 2016 Xtant Medical Holdings Inc Earnings Release - After Market Close|
biz.yahoo.com - March 10 at 6:43 AM
|Xtant™ Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period|
finance.yahoo.com - March 10 at 6:43 AM
|Xtant Medical to announce Fourth Quarter and Full Year 2016 Results on March 9th, 2017|
finance.yahoo.com - March 2 at 5:05 AM
|XTNT @ 35c This Low Floater Could Be A Big Gainer In 2017 And Beyond. Analysts Average PT Is $3.1/Share|
seekingalpha.com - February 2 at 6:56 AM
|Xtant Medical Holdings (XTNT) Announces Resignation of CEO Dan Goldberger|
www.streetinsider.com - January 24 at 5:26 AM
|Xtant Medical chief bids adieu|
seekingalpha.com - January 24 at 5:26 AM
|XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or P|
biz.yahoo.com - January 24 at 5:26 AM
|XTANT MEDICAL HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin|
biz.yahoo.com - January 21 at 6:01 AM
|Xtant Medical issues new convertible debt to cover $1.6M in interest obligations|
seekingalpha.com - January 19 at 4:32 PM
|Coverage initiated on Xtant Medical by Maxim Group|
us.rd.yahoo.com - December 8 at 2:19 PM